Follow-on RifAximin for the Prevention of recurrence following standard treatment of Infection with<i>Clostridium Difficile</i>(RAPID): a randomised placebo controlled trialGiles Major, Robert E. Spiller, Kirsty Sprange et al.|Gut|2018Cited by 34
PWE-050 Follow-on rifaximin for the prevention of recurrence in clostridium difficile associated diarrhoea: a randomised controlled trialGiles Major, Robert E. Spiller, Lucy Bradshaw et al.|Unknown|2017Cited by 0